Andrea Arleo

The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin

M. Copetti, A. Mangia, R. Santoro, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.

M. Copetti, A. Mangia, G. Spinzi, 2017, Journal of hepatology.

Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS/STING pathway

Y. Pommier, F. Ciccarelli, G. Capranico, 2022, British Journal of Cancer.

Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies

G. Pesole, D. Amadori, M. Copetti, 2019, EBioMedicine.

Balancing Affinity, Selectivity, and Cytotoxicity of Hydrazone-Based G-Quadruplex Ligands for Activation of Interferon β Genes in Cancer Cells

B. Pagano, G. Capranico, Jussara Amato, 2022, Journal of medicinal chemistry.